Hepatitis A virus surface antigens — Drug Target
All drugs that target Hepatitis A virus surface antigens — marketed and clinical-stage. Includes 2 drug classes acting on this target.
Drug classes
inactivated viral vaccine · Inactivated viral vaccine
Marketed (4)
- Hepatitis A (control) · International Vaccine Institute · inactivated viral vaccine · Immunology / Infectious Disease
This inactivated hepatitis A vaccine stimulates the immune system to produce antibodies against hepatitis A virus, providing protective immunity against infection. - Hepatitis A Virus · Novartis · Inactivated viral vaccine · Immunology / Infectious Disease
Hepatitis A Virus vaccine stimulates the immune system to produce antibodies against hepatitis A virus, providing protection against infection. - Hepatitis A vaccine · MacroGenics · inactivated viral vaccine · Immunology
Hepatitis A vaccine stimulates the immune system to produce antibodies against hepatitis A virus, providing protection against infection. - Healive® Lot 3 · Sinovac Biotech Co., Ltd · Inactivated viral vaccine · Immunology / Infectious Disease
Healive is an inactivated hepatitis A vaccine that stimulates the immune system to produce antibodies against hepatitis A virus.
Phase 3 pipeline (1)
- HAV vaccine · International Agency for Research on Cancer · Inactivated viral vaccine · Immunology / Infectious Disease
HAV vaccine stimulates the immune system to produce antibodies against hepatitis A virus, providing protection against infection.